Key Findings
Factors such as rising number of gynaecological diseases, technological advancement in product development and the growing popularity of minimally invasive procedures are all expected to drive growth in the global gynaecological devices market over the forecast period of 2018-2026. By the end of these projected years, the market is expected to register a CAGR of 8.42%.

Market Insights
The global gynaecological devices market is segmented on the basis of its products. The products are further segmented into surgical devices, endoscopy devices, endometrial ablation devices, fluid management systems, female sterilization/contraceptive devices, hand instruments and diagnostic imaging devices. Surgical devices include hysteroscope, colposcope, resectoscope, laparoscope and endoscopic imaging systems. Endometrial ablation is done through hydrothermal ablation, radiofrequency ablation devices, balloon ablation devices and other ablation devices. Contraceptive devices include permanent birth control, IUD, intravaginal rings and subdermal contraceptive implants, while the hand instruments include vaginal speculum, tenaculum, curettes, trocars, biopsy forceps and others hand instruments.

Regional Insights
Geographical segmentation of the global gynaecology devices market is done into North America, Asia-Pacific, Europe and rest of the World. By the end of the forecast period, North America is expected to account for the highest revenue share. The healthcare infrastructure is considerably advanced in this region as compared to other regional markets. On the other hand, the Asia-Pacific market is forecasted to display the highest CAGR by the end of 2026. The region has a high prevalence rate of STDs. This, coupled with the lack of awareness about contraceptive devices provides a major scope for the gynaecology devices market to expand in this region.

Competitive Insights
Market companies like Boston Scientific Corporation, Coopersurgical Inc, Ethicon Inc, Hologic Inc, Karl Storz Gmbh & Co. Kg, Medtronic Plc, Olympus Corporation, Ovascience, Pfizer, Stryker Corporation, Ocon Medical Ltd, and Teva Pharmaceutical Industries Limited are catering to the global gynaecology devices industry.